top of page
Search

Unmasking Cardiovascular Risk Beyond Conventional Testing Mistakes in Assessing Plaque Buildup

May 14
5 min read

Heart disease remains a leading cause of death worldwide, yet many people with seemingly normal test results still face unexpected cardiac events. Traditional methods like imaging, calcium scoring, and standard cholesterol tests often miss critical signs of dangerous plaque buildup in arteries. This gap in detection leaves many at risk, even when their numbers look good on paper. Understanding the limits of conventional testing and exploring more personalized approaches can help uncover hidden risks and guide better prevention and treatment.


Close-up view of a cross-section of an artery showing plaque buildup
Detailed artery cross-section highlighting plaque accumulation

Why Standard Tests Miss Dangerous Plaque


Most cardiovascular risk assessments rely on imaging techniques such as coronary calcium scoring and blood tests measuring cholesterol levels. While these tools provide useful information, they have significant blind spots:


  • Calcium score limitations

Calcium scoring detects calcified plaque but does not capture soft, lipid-rich plaques. These soft plaques are more prone to rupture, causing heart attacks. A zero calcium score does not guarantee the absence of dangerous plaque PMID: 29723329


  • Cholesterol tests overlook crucial, potentially life-saving markers

Standard cholesterol panels measure total cholesterol, LDL, HDL, and triglycerides. However, they do not assess important indicators like apolipoprotein B (ApoB), lipoprotein(a) (Lp(a)), LDL particle size, or LDL oxidation status. These missing markers are critical to understanding plaque predispositions PMC11219008: https://www.jacc.org/doi/10.1016/j.jacc.2017.10.024



Understanding the Complexity of Plaque Buildup


Plaque formation in arteries is a complex biological process influenced by genetics, lifestyle, inflammation, and metabolic factors. Not all plaque is the same:


  • Soft vs. calcified plaque

Soft plaques contain fatty deposits and inflammatory cells, making them unstable. Calcified plaques are hardened and more stable but still contribute to narrowing arteries.


  • Role of inflammation and oxidation

Oxidized LDL particles trigger inflammation, accelerating plaque growth and instability. Measuring LDL oxidation can provide insight into ongoing damage.


  • Role of endothelial health

If the endothelium of the arteries is unhealthy, plaque can accumulate easily. Evaluating this through a biomarker strategy is crucial to determine which interventions should be implemented for endothelial health. See here for more information on endothelial health


  • Genetic factors like Lp(a)

Elevated Lp(a) is a strong inherited risk factor for cardiovascular disease, often overlooked in standard tests.


Why Low Cholesterol and Zero Calcium Scores Can Be Misleading


Many people with low LDL cholesterol, triglycerides, and zero calcium scores believe they are at low risk. Yet, unexpected cardiac events still occur in this group. This paradox happens because:


  • Hidden soft plaques are not detected

Imaging and cholesterol tests do not reveal soft plaques or inflammatory activity.


  • Individual biological differences matter

Some people have genetic predispositions or metabolic profiles that increase risk despite normal standard tests.


  • Incomplete risk assessment

Without measuring ApoB, Lp(a), LDL particle size, and oxidation, clinicians miss key signals.


Building a Personalized Biological Framework for Cardiovascular Health


Although science has not yet reached a point where standardization is feasible PMID: 40185865, molecular guides have the ability to observe the complete biological landscape without being overwhelmed by vast amounts of data. This enables them to make connections that most clinicians are unable to, due to limitations in time or resources..


To manage cardiovascular risk effectively, patients need a tailored approach combining clinical expertise and molecular insights:


  • Comprehensive testing

Include advanced lipid testing (ApoB, Lp(a), LDL particle size), inflammatory markers (hs-CRP), and imaging beyond calcium scoring (CT angiography, MRI).


  • Genetic screening

Identify inherited risk factors like elevated Lp(a) or familial hypercholesterolemia. A molecular guide is essential here. Molecular guides have evaluated various genomic test kits, and Sequencing has met the stringent molecular criteria. Testing is straightforward, and they offer raw data on your complete genome.


  • Individualized treatment plans

Match medical, herbal and dietary interventions to the patient’s unique biology to minimize side effects and maximize benefit.

  • Example: Muscle pain and side effects from treatments  

  Many patients experience muscle pain from statins or other interventions. This pain can signal underlying issues with muscle function, which is vital for overall health. Sometimes, treatments do not match the individual's biology, leading to side effects without addressing the true plaque buildup. This type of muscle side effect can lead to serious complications PMID: 24799748. This issue can be managed by recognizing genetic tendencies and opting for a different statin or a lower dose, while increasing CoQ10. These strategies are not widely used in most clinics and rely more on trial and error. Molecular guides can assist in customizing these strategies, providing the clinician with a more personalized framework to operate within.


  • Ongoing monitoring

Consistent monitoring using both clinical and molecular markers is essential to assess plaque progression or regression. Molecular guides emphasize the importance of testing at least monthly, and once stabilized, every three months. This frequency is necessary due to numerous variables, such as diet, microbiome, and inflammatory health, which can easily cause changes in the numbers.


Practical Steps to Take Control of Your Heart Health


If you or someone you know has been told their cholesterol or calcium score is normal but still worries about heart disease, consider these actions:


  • Ask for advanced lipid testing

Request ApoB, Lp(a), and LDL particle size tests from your healthcare provider.

If your healthcare provider believes it is unnecessary, you can test here through Quest independently. If finances are limited, molecular guides can help with strategies to have this panel covered by insurance.


  • Discuss inflammation and oxidation

Inquire about markers like hs-CRP and LDL oxidation status.


  • Discuss CCTA vs. calcium score  

  Consider asking about a different imaging test, such as CCTA, which can visualize both hard and soft plaque. Note that both the calcium score test and CCTA involve radiation exposure, but CCTA has a higher level. Evaluate advanced lipid markers to choose the appropriate imaging test and reduce radiation exposure. Consult a molecular guide to discuss herbs that offer radiation protection. Test to understand your sensitivity to radiation (refer to the molecular guide). Some individuals are more susceptible to radiation-induced damage and may need additional protection.


  • Explore genetic testing

Understand your inherited risk factors. A molecular guide is essential in this domain.


  • Find a Molecular Guide

Locate a molecular scientist skilled in linking biological elements through molecular frameworks. The science is still developing, and no one has definitive answers about what works for whom and why. Although molecular tests are widely available, they are not well-known. A molecular guide educates on physiological and pathophysiological mechanisms, directs where to access the most advanced tests, and, once the data is available, connects the findings. They also teach the patient how these connections work, ensuring both the clinician and patient have a personalized framework before beginning any interventions. See here and here for molecular guidance examples.


  • Seek a clinician experienced in personalized cardiovascular care  

Find a doctor or specialist who is knowledgeable in advanced, cutting-edge cardiology and applies it in clinical practice. Molecular guides assist in identifying clinicians who specialize in your biological profile.


  • Consider lifestyle and tailored supplements

Work with your healthcare team to develop a plan that fits your biology, reducing side effects like muscle pain.


The Hidden Storm: Why Awareness Matters


Ignoring the limitations of conventional tests can leave a dangerous storm brewing unnoticed. Many people with low cholesterol and zero calcium scores PMID: 29723329 have died suddenly from heart attacks caused by soft plaque rupture. Knowing your unique risk factors and biological profile helps you intervene early and effectively.


This approach transforms cardiovascular care from a one-size-fits-all model to a precise, personalized strategy. It empowers you to take control of your heart health with confidence, reducing the chance of unexpected events.


This is not medical advice and is intended solely for educational purposes. Share molecular frameworks with your doctor, who will then provide guidance on clinical decisions.



 
 
 

Comments


©2020 by WellOne Team. Proudly created with Wix.com

bottom of page